This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here
Our Blog
SunRock Biopharma and IDIS secure 1.8 million euros in funding for the IMPANC project.
27/02/2023This initiative aims to advance the study of a new and effective therapeutic alternative that improves the lives of pancreatic cancer…
Read More
SunRock Biopharma receives the Bioga Award as a Competitive BioCompany
20/01/2023The company’s experience and trajectory in the development of cancer treatments have made SunRock worthy of this recognition. The Business Technology…
Read More
Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein
21/09/2022Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours LONDON and SANTIAGO DE COMPOSTELA, Spain,…
Read More
